Astex Announces Drug Discovery Collaboration with the Institute of Cancer Research and Cancer Research Technology
20 mars 2003 03h29 HE
|
Astex Therapeutics
CAMBRIDGE, U.K., March 20, 2003 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced an exclusive research collaboration and licence agreement with the...
ViroPharma Announces the Initiation of Phase 1 Hepatitis C Trials and Updates its Product Pipeline and Convertible Notes
03 janv. 2003 09h43 HE
|
ViroPharma Incorporated
EXTON, Pa., Jan. 3, 2003 (PRIMEZONE) -- ViroPharma Incorporated (Nasdaq:VPHM) today announced that, together with Wyeth, it has initiated phase 1 human clinical trials with HCV 371, the lead compound...
![Akzo Nobel](/news-release/logo/214601/0/214601.gif?lastModified=12%2F09%2F2016%2023%3A55%3A35&size=2)
Akzo Nobel and Organon Considering Next Moves Following Adverse Summary Judgement Ruling in Remeron Lawsuit Against Generics
19 déc. 2002 02h56 HE
|
Akzo Nobel
ARNHEM, The Netherlands and WEST ORANGE, N.J., Dec. 19, 2002 (PRIMEZONE) -- Akzo Nobel (Nasdaq:AKZOY) and Organon Inc. confirm that the U.S. Federal District Court in Newark, NJ, has granted summary...
Medivir and Paradigm Enter Alliance
13 déc. 2002 08h25 HE
|
Medivir
HUDDINGE, Sweden, Dec. 13, 2002 (PRIMEZONE) -- Medivir and Paradigm Therapeutics Ltd (Cambridge, U.K.) have entered a broad-based, 3-year research collaboration to identify novel protease drug...
Pharmexa Announces that GlaxoSmithKline has Exclusive Option on HER-2 Protein Breast Cancer Project
12 avr. 2002 05h07 HE
|
Pharmexa A/S
HORSHOLM, Denmark, April 12, 2002 (PRIMEZONE) -- In June 2001 Pharmexa announced that it had in-licensed a vector-cell production system from GlaxoSmithKline (NYSE:GSK) for use in Pharmexa's...